We can't find the internet
Attempting to reconnect
Something went wrong
Hang in there while we get back on track
£108.00
Springer - Resistance to Immunotherapeutic Antibodies in Cancer
Price data last checked 55 day(s) ago - refreshing...
We'll watch every seller, every day. One email when your price arrives.
This is the most expensive it has ever been. Walk away.
£108 today · previous high £108 · all-time low £108
NEW HERE?
Amazon shows you one price. We show you all of them.
Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.
WHAT'S ON THIS PAGE
when this has been cheap or pricey
where the price is heading next
all-time high & low, recent range
name your number, we'll email you
Price History & Forecast
Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.
Last 36 days · 36 data points (no recent data)
Price Distribution
Price distribution over 36 days • 1 price levels
Price Analysis
Most common price: £108 (36 days, 100.0%)
Price range: £108 - £108
Price levels: 1 different prices over 36 days
Description
Key Features
Examines antibody-mediated anti-cancer therapy as a less toxic and more selective alternative to traditional chemotherapy and radiation.
Provides insight into how monoclonal antibodies (mAbs) work to destroy malignant tumor cells and block specific cell receptors.
Explores methods and strategies used to reverse drug and radiation resistance in cancer patients.
Part of the specialized Resistance to Targeted Anti-Cancer Therapeutics series for advanced medical study.
Focuses on the mechanisms of monoclonal antibodies to prevent tumor growth and target cancer cells specifically.
Product Specifications
- Brand
- Springer
- Format
- hardcover
- ASIN
- 1461476534
- Domain
- Amazon UK
- Release Date
- 05 August 2013
- Listed Since
- 04 April 2013
Barcode
No barcode data available
Similar Products You Might Like
Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives
Academic Press
Tumor Immunology: Methods and Protocols: 1393 (Methods in Molecular Biology, 1393)
Humana
Academic Press - Multifaceted Role of IL-1 in Cancer and Inflammation
Academic Press
Cancer Immunotherapy: Immune Suppression and Tumor Growth
Academic Press
Cancer Immunotherapy: Immune Suppression and Tumor Growth
Academic Press
Cancer Immunology: Innovative Approaches to Therapy: 27 (Cancer Treatment and Research, 27)
Springer
Cancer Immunology: Innovative Approaches to Therapy: 27 (Cancer Treatment and Research)
Springer
Infections Related to Biologics, An Issue of Infectious Disease Clinics of North America: Volume 34-2 (The Clinics: Internal Medicine, Volume 34-2)
Elsevier
Immune Mediators in Cancer: Methods and Protocols: 2108 (Methods in Molecular Biology)
Humana
Basic Immunology: Functions and Disorders of the Immune System
Elsevier
Humana Cancer Immunosurveillance: Methods and Protocols 1884
Humana
Springer - Immunotherapy of Cancer: An Innovative Treatment
Springer
Biomarkers for Immunotherapy of Cancer: Methods and Protocols: 2055 (Methods in Molecular Biology, 2055)
Humana
Regulatory B Cells: Methods and Protocols: 1190 (Methods in Molecular Biology)
Humana
Humana Immune Receptors: Methods and Protocols 748 Book
Humana
A Beginner's Guide to Targeted Cancer Treatments and Cancer Immunotherapy
Wiley
Advances in Immunology: 95: Volume 95
Academic Press
Tumor-Induced Immune Suppression: Mechanisms and Therapeutic Reversal
Springer
Advances in Immunology: 92: Volume 92
Academic Press
Advances in Immunology: v. 96: Volume 96
Academic Press
Advances in Immunology: Volume 149
Academic Press
Tumor Antigens Recognized by T Cells and Antibodies: 3 (Tumour Immunology and Immunotherapy Series)
CRC Press